share_log

海王生物(000078.SZ):目前已搭建了多元化、多层次的医药制药产品结构

Haiwang Biotech (000078.SZ): It has now built a diversified, multi-level pharmaceutical product structure

Gelonghui Finance ·  Feb 5 19:55

Gelonghui, Feb. 5 | Haiwang Biotech (000078.SZ) said on the investor interactive platform that the company's pharmaceutical industry sector is mainly engaged in drug R&D, production and sales, with subsidiaries Haiwangfu Pharmaceutical, Jinxiang Traditional Chinese Medicine and Haiwang Zhongxin Pharmaceutical as the main platforms. The company has now built a diversified and multi-level pharmaceutical product structure. Haiwang Pharmaceutical's main business is R&D, production and sales of large infusion products, Western medicine preparations, etc.; Jinxiang Traditional Chinese Medicine is a medium-sized traditional Chinese medicine manufacturer and sales enterprise in Fujian Province, responsible for R&D, production and sales of proprietary Chinese medicines; Haiwang Zhongxin Pharmaceutical is a comprehensive pharmaceutical enterprise integrating R&D, production and sales of pharmaceutical products.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment